Patents-Review.com
🔗 Permalink
Assignee profile:

MORPHOSYS AG

City:

Martinsried

Country:

Germany

Published Applications:

18

Last publication date:

2020-01-23

Patent Grants:

16

Last grant date:

2021-06-08

Top Inventors for applications by MORPHOSYS AG

These are the the leading inventors for applications assigned to MORPHOSYS AG:

Recent patent applications by MORPHOSYS AG

MORPHOSYS AG based in Martinsried, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-01-23 ✅ Patent 11,028,165 granted on 2021-06-08
US20200024340A1
Chemistry; metallurgy

Nucleic acid encoding anti-GM-CSF antibodies

 #2 | 2017-08-03 ✅ Patent 10,377,820 granted on 2019-08-13
US20170218061A1
Chemistry; metallurgy

Methods of treatment using anti-GM-CSF antibodies

 #3 | 2015-01-15 ✅ Patent 9,289,490 granted on 2016-03-22
US20150017160A1
Human necessities

Combinations and uses thereof

 #4 | 2013-09-12 ✅ Patent 8,728,981 granted on 2014-05-20
US20130236902A1
Physics

Collection and methods for its use

 #5 | 2013-05-30
US20130136747A1
Chemistry; metallurgy

ANTI-AMYLOID BETA ANTIBODIES AND THEIR USE

 #6 | 2012-09-06 ✅ Patent 8,329,886 granted on 2012-12-11
US20120225478A1
Chemistry; metallurgy

Nucleic acid molecules encoding anti-amyloid beta antibodies

 #7 | 2012-03-29 ✅ Patent 8,685,896 granted on 2014-04-01
US20120077713A1
Chemistry; metallurgy

Collection and methods for its use

 #8 | 2012-03-01 ✅ Patent 8,486,394 granted on 2013-07-16
US20120052078A1
Human necessities

Generation and Profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38

 #9 | 2011-08-18 ✅ Patent 9,267,952 granted on 2016-02-23
US20110200589A1
Physics

Deconvolution method

 #10 | 2011-02-24 ✅ Patent 9,751,939 granted on 2017-09-05
US20110045000A1
Chemistry; metallurgy

Anti-GM-CSF antibodies

 #11 | 2010-07-08 ✅ Patent 8,216,577 granted on 2012-07-10
US20100172907A1
Chemistry; metallurgy

Anti-Aβ antibodies and their use

 #12 | 2009-11-05 ✅ Patent 8,062,637 granted on 2011-11-22
US20090274702A1
Human necessities

Methods of ameliorating inflammatory disease using an uPA antagonist

 #13 | 2009-10-08 ✅ Patent 8,088,896 granted on 2012-01-03
US20090252733A1
Human necessities

Generation and profiling of fully human gold-derived therapeutic antibodies specific for human CD38

 #14 | 2009-05-14
US20090123950A1
Chemistry; metallurgy

Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38

 #15 | 2009-04-02 ✅ Patent 8,273,688 granted on 2012-09-25
US20090088346A1
Chemistry; metallurgy

Collection of HCDR3 regions and uses therefor

 #16 | 2009-02-26 ✅ Patent 7,867,495 granted on 2011-01-11
US20090053213A1
Chemistry; metallurgy

Anti-GM-CSF antibodies and uses therefor

 #17 | 2008-01-31 ✅ Patent 8,513,164 granted on 2013-08-20
US20080026948A1
Chemistry; metallurgy

Protein (poly)peptides libraries

 #18 | 2005-08-04 ✅ Patent 7,794,719 granted on 2010-09-14
US20050169925A1
Chemistry; metallurgy

Anti-amyloid β antibodies

Also check out MORPHOSYS AG's (Martinsried, Germany) applicant profile with 3 patent applications submitted.

AssigneeID:

125053 ⎘